Sleep Cycle (SLEEP) Hisse Özeti
Sleep Cycle AB (publ), İsveç'te uyku takibi uygulamaları sağlamakla ilgilenmektedir. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 3/6 |
| Gelecekteki Büyüme | 4/6 |
| Geçmiş Performans | 3/6 |
| Finansal Sağlık | 6/6 |
| Temettüler | 3/6 |
Ödüller
Risk Analizi
SLEEP Community Fair Values
Create NarrativeSee what 67 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
Sleep Cycle AB (publ) Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | SEK 24.60 |
| 52 Haftanın En Yüksek Seviyesi | SEK 32.30 |
| 52 Haftanın En Düşük Seviyesi | SEK 14.84 |
| Beta | 0.072 |
| 1 Aylık Değişim | 0.20% |
| 3 Aylık Değişim | 40.57% |
| 1 Yıllık Değişim | -21.03% |
| 3 Yıllık Değişim | -2.77% |
| 5 Yıllık Değişim | -65.74% |
| Halka arzdan bu yana değişim | -69.17% |
Son Haberler & Güncellemeler
Anlatı Güncellemesi • Jul 02
SLEEP: Takeover Offer And Data Partnerships Will Shape Balanced Future Prospects
Analysts have revised their price target on Sleep Cycle to SEK26.0 from SEK34.5. This reflects updated views on the company’s fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News for Sleep Cycle Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB, has proposed to acquire Sleep Cycle AB (publ) for approximately SEK500 million, offering a cash consideration of SEK24.5 per share.
Anlatı Güncellemesi • Jun 18
SLEEP: Apnea Launch And AI Sleep Scoring Will Support Margin Recovery
Analysts have kept their SEK 35.0 price target for Sleep Cycle unchanged, citing updated assumptions that include slightly higher discount rates, revised revenue growth expectations, a materially higher profit margin outlook, and a lower future P/E multiple as key reasons for maintaining this fair value view. What’s in the News for Sleep Cycle Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB, has proposed to acquire Sleep Cycle AB (publ) for approximately SEK 500 million in cash, at SEK 24.5 per share.
Anlatı Güncellemesi • Jun 04
SLEEP: Medical Sleep Apnea Breakthrough And AI Coaching Will Drive Long Term Upside
Analysts have raised their price target on Sleep Cycle from SEK 28.83 to SEK 30.50, citing updated assumptions around revenue growth, profit margins and future P/E levels as key drivers behind the new valuation view. What's in the News Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB, has proposed to acquire Sleep Cycle AB (publ) for approximately SEK 500 million in cash, offering SEK 24.50 per share.Anlatı Güncellemesi • May 07
SLEEP: Respiratory Research And Sleep Apnea Solution Will Drive Long Term Upside
Analysts have trimmed their price target on Sleep Cycle from SEK30.75 to about SEK28.83, citing updated assumptions for the discount rate, revenue growth, profit margins and future P/E multiples. What's in the News Sleep Cycle renewed its partnership with Revolut through June 2027, keeping the app included in exclusive offerings for Premium, Metal and Ultra customers and giving access to a large, premium user base for its sleep optimization features (Client Announcements).Recent updates
Anlatı Güncellemesi • Jul 02
SLEEP: Takeover Offer And Data Partnerships Will Shape Balanced Future Prospects
Analysts have revised their price target on Sleep Cycle to SEK26.0 from SEK34.5. This reflects updated views on the company’s fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News for Sleep Cycle Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB, has proposed to acquire Sleep Cycle AB (publ) for approximately SEK500 million, offering a cash consideration of SEK24.5 per share.Anlatı Güncellemesi • Jun 18
SLEEP: Apnea Launch And AI Sleep Scoring Will Support Margin Recovery
Analysts have kept their SEK 35.0 price target for Sleep Cycle unchanged, citing updated assumptions that include slightly higher discount rates, revised revenue growth expectations, a materially higher profit margin outlook, and a lower future P/E multiple as key reasons for maintaining this fair value view. What’s in the News for Sleep Cycle Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB, has proposed to acquire Sleep Cycle AB (publ) for approximately SEK 500 million in cash, at SEK 24.5 per share.Anlatı Güncellemesi • Jun 04
SLEEP: Medical Sleep Apnea Breakthrough And AI Coaching Will Drive Long Term Upside
Analysts have raised their price target on Sleep Cycle from SEK 28.83 to SEK 30.50, citing updated assumptions around revenue growth, profit margins and future P/E levels as key drivers behind the new valuation view. What's in the News Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB, has proposed to acquire Sleep Cycle AB (publ) for approximately SEK 500 million in cash, offering SEK 24.50 per share.Anlatı Güncellemesi • May 07
SLEEP: Respiratory Research And Sleep Apnea Solution Will Drive Long Term Upside
Analysts have trimmed their price target on Sleep Cycle from SEK30.75 to about SEK28.83, citing updated assumptions for the discount rate, revenue growth, profit margins and future P/E multiples. What's in the News Sleep Cycle renewed its partnership with Revolut through June 2027, keeping the app included in exclusive offerings for Premium, Metal and Ultra customers and giving access to a large, premium user base for its sleep optimization features (Client Announcements).Analiz Makalesi • May 02
Earnings Release: Here's Why Analysts Cut Their Sleep Cycle AB (publ) (STO:SLEEP) Price Target To kr29.00
It's been a sad week for Sleep Cycle AB (publ) ( STO:SLEEP ), who've watched their investment drop 17% to kr15.34 in...Anlatı Güncellemesi • Apr 21
SLEEP: Respiratory Research And Apnea Launch Will Support 2027 Margin Recovery
Analysts keep their SEK35.0 price target for Sleep Cycle unchanged, citing offsetting shifts in key model inputs such as slightly lower revenue growth assumptions, a reduced profit margin outlook, a marginally lower discount rate and a higher future P/E multiple. What's in the News Sleep Cycle renewed its partnership with Revolut through June 2027, keeping its premium features bundled into Revolut’s Premium, Metal and Ultra tiers and extending reach to Revolut’s global user base (Client Announcements).Anlatı Güncellemesi • Apr 04
SLEEP: Respiratory Disease Research Collaboration Will Drive Long Term Upside Potential
Analysts now see Sleep Cycle's fair value at SEK 30.75, down from SEK 39.50, reflecting updated views on revenue growth, profit margins and an outlook that applies a higher discount rate along with a much higher future P/E assumption. What's in the News Sleep Cycle introduced an AI-powered Sleep Score that focuses on duration, quality and routine.Anlatı Güncellemesi • Mar 21
SLEEP: Respiratory Research Collaborations Will Support 2027 Margin Recovery Upside
Analysts have maintained their SEK 35.00 price target on Sleep Cycle, with only small tweaks to assumptions around discount rate, revenue, profit margin and future P/E, reflecting a broadly steady outlook on the shares. What's in the News Sleep Cycle began a five-year research collaboration with The Delphi Group at Carnegie Mellon University, providing deidentified sleep-based cough and breathing data to support research on respiratory disease surveillance and early detection of seasonal and emerging outbreaks, including influenza, RSV and SARS-CoV-2.Anlatı Güncellemesi • Mar 06
SLEEP: Research Partnerships And 2027 Margin Recovery Will Drive Long Term Upside
Analysts are keeping their SEK price target for Sleep Cycle unchanged. A fair value of SEK 35.00 is maintained, as small adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions effectively offset one another.Anlatı Güncellemesi • Feb 19
SLEEP: Licensing Deals And 2027 Margin Recovery Will Drive Long Term Upside
Analysts have reduced their Sleep Cycle fair value estimate from SEK 43.0 to SEK 35.0, reflecting a higher discount rate, a lower assumed future P/E, and slightly softer margin expectations, partly offset by a higher projected revenue growth rate. What's in the News Sleep Cycle issued earnings guidance indicating an EBIT margin of about 5% for 2026, linked to increased forward-looking investments.Analiz Makalesi • Feb 09
These Analysts Just Made An Downgrade To Their Sleep Cycle AB (publ) (STO:SLEEP) EPS Forecasts
One thing we could say about the analysts on Sleep Cycle AB (publ) ( STO:SLEEP ) - they aren't optimistic, having just...Analiz Makalesi • Feb 07
Sleep Cycle (STO:SLEEP) Has Announced That Its Dividend Will Be Reduced To SEK0.53
Sleep Cycle AB (publ) ( STO:SLEEP ) is reducing its dividend from last year's comparable payment to SEK0.53 on the 20th...Anlatı Güncellemesi • Feb 04
SLEEP: Data Partnerships Will Drive Future Upside For This Undervalued Play
Analysts have lifted their price target for Sleep Cycle from $26.00 to $34.50, citing updated assumptions that combine a lower discount rate and higher projected profit margin with a different revenue growth outlook and a higher future P/E multiple. What's in the News Sleep Cycle and the UK Health Security Agency began a 12 week research collaboration to test whether anonymised, privacy preserved data from the Sleep Cycle app and its Cough Radar tool can support respiratory disease surveillance and early detection of patterns for viruses such as influenza, RSV and Covid 19 (Key Developments).Anlatı Güncellemesi • Jan 21
SLEEP: Expanding Licensing And AI Coaching Will Drive Long Term Upside
Analysts have maintained their fair value estimate for Sleep Cycle at $43.00. They cite more cautious assumptions on revenue growth and profit margins, together with a higher future P/E outlook, as key factors behind the unchanged target.Anlatı Güncellemesi • Jan 06
SLEEP: Expanding Licensing And AI Sleep Coaching Will Support Long Term Upside
Analysts have kept their fair value estimate for Sleep Cycle steady at US$43.00, pointing to only small tweaks in the discount rate, expected revenue growth and profit margin, along with a slightly lower future P/E assumption as the basis for the unchanged target. What's in the News Sleep Cycle signed a multi year SDK licensing agreement with a global IoT and smart home device brand, allowing the customer to integrate the company’s audio based sleep tracking analysis into its devices and broadening Sleep Cycle’s technology licensing activity (Key Developments).Analiz Makalesi • Jan 04
There's No Escaping Sleep Cycle AB (publ)'s (STO:SLEEP) Muted Earnings
Sleep Cycle AB (publ)'s ( STO:SLEEP ) price-to-earnings (or "P/E") ratio of 9.2x might make it look like a strong buy...Anlatı Güncellemesi • Dec 15
SLEEP: Long Term Profit Margins Will Drive Stronger Future Upside Potential
Analysts have trimmed their price target on Sleep Cycle from approximately $49.00 to $43.00. This reflects expectations for slower revenue growth, partially offset by higher long term profit margins and a lower future price to earnings multiple.Analiz Makalesi • Sep 09
Sleep Cycle AB (publ) (STO:SLEEP) Held Back By Insufficient Growth Even After Shares Climb 30%
Sleep Cycle AB (publ) ( STO:SLEEP ) shares have had a really impressive month, gaining 30% after a shaky period...Analiz Makalesi • Aug 27
Weekly Picks: 💸 A dividend-rich sleep-tech play few investors are watching, and 2 other picks.
The main catalyst behind Sleep Cycle’s upside potential, why JB Hi-Fi might have lost its point of difference, and the bear, base and bull case for Figma.
Anlatı Güncellemesi • Aug 23
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Q2 2025 Update (updated 250823) Subscriptions continue to decline (-3%), leading to a top-line contraction that is likely to persist. However, partnerships are gaining momentum , with the company highlighting on the conference call that these could carry a more favorable margin profile.Anlatı Güncellemesi • Aug 22
Expanding Technology And Sleep Apnea Initiatives Will Open New Opportunities
Sleep Cycle’s consensus price target has been revised upward, driven primarily by an increase in its future P/E multiple and a modest improvement in net profit margin, resulting in a new fair value estimate of SEK44.75. What's in the News Launched in-app promotion platform in collaboration with HelloFresh, Factor, and YouFoodz, enabling external brands to target Sleep Cycle’s user base with curated wellness offers and supporting expansion of partnership programs.Analiz Makalesi • Apr 30
Earnings Update: Sleep Cycle AB (publ) (STO:SLEEP) Just Reported And Analysts Are Trimming Their Forecasts
As you might know, Sleep Cycle AB (publ) ( STO:SLEEP ) last week released its latest first-quarter, and things did not...Analiz Makalesi • Apr 29
The Market Doesn't Like What It Sees From Sleep Cycle AB (publ)'s (STO:SLEEP) Earnings Yet As Shares Tumble 34%
Sleep Cycle AB (publ) ( STO:SLEEP ) shares have had a horrible month, losing 34% after a relatively good period...Analiz Makalesi • Apr 08
Sleep Cycle's (STO:SLEEP) Dividend Will Be Increased To SEK3.00
Sleep Cycle AB (publ) ( STO:SLEEP ) has announced that it will be increasing its dividend from last year's comparable...
Yeni Anlatı • Mar 18
Medical-Grade Sleep Apnea Certification Will Open New Healthcare Partnerships
Exploring medical-grade certification and new revenue streams could enhance profitability, opening healthcare markets through partnerships and innovation.Analiz Makalesi • Mar 06
Sleep Cycle's (STO:SLEEP) Upcoming Dividend Will Be Larger Than Last Year's
Sleep Cycle AB (publ) ( STO:SLEEP ) has announced that it will be increasing its dividend from last year's comparable...Analiz Makalesi • Feb 10
Sleep Cycle (STO:SLEEP) Is Paying Out A Larger Dividend Than Last Year
Sleep Cycle AB (publ) ( STO:SLEEP ) will increase its dividend from last year's comparable payment on the 15th of April...Yeni Anlatı • Feb 10
Sleep Cycle's Revenue Set to Rise 10% with Strong Business Model
Company will continue its trajectory of 10% top line growth p.a. with possibility of more aggressive growth should new business materialize (e.g. data monetization or making the app medical device forHissedar Getirileri
| SLEEP | SE Software | SE Pazar | |
|---|---|---|---|
| 7D | 0.2% | -2.0% | -0.7% |
| 1Y | -21.0% | -31.8% | 8.7% |
Getiri vs. Endüstri: SLEEP geçen yıl % -31.8 oranında getiri sağlayan Swedish Software sektörünü aştı.
Getiri vs Piyasa: SLEEP geçen yıl % 8.7 oranında getiri sağlayan Swedish Piyasasının altında performans gösterdi.
Fiyat Oynaklığı
| SLEEP volatility | |
|---|---|
| SLEEP Average Weekly Movement | 14.1% |
| Software Industry Average Movement | 8.1% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 12.8% |
| 10% least volatile stocks in SE Market | 3.5% |
İstikrarlı Hisse Senedi Fiyatı: SLEEP hisse senedi fiyatı, son 3 ayda Swedish piyasasına kıyasla dalgalı seyretti.
Zaman İçindeki Volatilite: SLEEP 'nin haftalık oynaklığı ( 14% ) geçen yıl boyunca sabit kaldı, ancak hala Swedish hisselerinin %75'inden yüksek.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 2001 | 40 | Erik Jivmark | sleepcycle.com |
Sleep Cycle AB (publ), İsveç'te uyku izleme uygulamaları sağlamakla ilgilenmektedir. Uyku ve sağlık platformları geliştirmektedir. Şirket, uyku ile ilgili çözümler sağlayan bir uygulama olan Sleep Cycle uygulamasını sunmaktadır.
Sleep Cycle AB (publ) Temel Bilgiler Özeti
| SLEEP temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | SEK 498.83m |
| Kazançlar(TTM) | SEK 44.92m |
| Gelir(TTM) | SEK 235.53m |
11.1x
F/K Oranı2.1x
P/S OranıSLEEP aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| SLEEP gelir tablosu (TTM) | |
|---|---|
| Gelir | SEK 235.53m |
| Gelir Maliyeti | SEK 100.65m |
| Brüt Kâr | SEK 134.88m |
| Diğer Giderler | SEK 89.96m |
| Kazançlar | SEK 44.92m |
Son Raporlanan Kazançlar
Mar 31, 2026
Sonraki Kazanç Tarihi
Aug 26, 2026
| Hisse başına kazanç (EPS) | 2.22 |
| Brüt Marj | 57.27% |
| Net Kâr Marjı | 19.07% |
| Borç/Özkaynak Oranı | 0% |
SLEEP uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünTemettüler
2.2%
Mevcut Temettü Verimi24%
Ödeme OranıŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/07/09 05:56 |
| Gün Sonu Hisse Fiyatı | 2026/07/09 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları GitHub sayfamızda mevcuttur; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Sleep Cycle AB (publ) 4 Bu analistlerden 1, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Oscar Erixon | Carnegie Investment Bank AB |
| Erik Granström | DNB Carnegie |
| Rikard Engberg | DNB Carnegie Commissioned Research |